The Scientist

» public health and immunology

Most Recent

image: Ebola Scare in DC

Ebola Scare in DC

By | October 17, 2014

The Scientist senior editor, Jef Akst, is communicating via cell phone with her parents, who were on the bus briefly occupied by an ill woman who was later escorted by hazmat teams to the hospital.

1 Comment

image: US Nurse Contracts Ebola

US Nurse Contracts Ebola

By | October 14, 2014

Despite wearing protective gear, a nurse at Texas Health Presbyterian Hospital in Dallas who helped treat the first US Ebola patient has tested positive for the virus.

0 Comments

image: Spain and U.S. Deal with Ebola

Spain and U.S. Deal with Ebola

By | October 8, 2014

The first case of Ebola contracted outside of West Africa has the Spanish government scrambling to contain the deadly virus. In the U.S., the first person diagnosed with Ebola in the country has died.

0 Comments

image: Java Genes?

Java Genes?

By | October 8, 2014

Eight genetic loci could partially explain why some people drink more coffee than others.

0 Comments

image: Epigenetics of Trained Innate Immunity

Epigenetics of Trained Innate Immunity

By | September 25, 2014

Documenting the epigenetic landscape of human innate immune cells reveals pathways essential for training macrophages.

2 Comments

image: UN Calls for $600M in Aid to Stop Ebola

UN Calls for $600M in Aid to Stop Ebola

By | September 4, 2014

The United Nations and medical organizations request additional international action on Ebola as the pace of the ongoing epidemic accelerates.

0 Comments

image: Ebola’s Toll on Healthcare Workers

Ebola’s Toll on Healthcare Workers

By | August 26, 2014

“Unprecedented number of medical staff infected with Ebola,” the World Health Organization says.

2 Comments

image: For Polio, Two Vaccines Work Better Than One

For Polio, Two Vaccines Work Better Than One

By | August 21, 2014

A booster dose of inactivated polio vaccine bolsters the immune system and reduces viral shedding in children already treated with the oral polio vaccine, a study shows. 

1 Comment

image: WHO OKs Experimental Ebola Drugs

WHO OKs Experimental Ebola Drugs

By | August 13, 2014

But biotech firms’ supplies are dwindling.

0 Comments

image: Ebola on the Move

Ebola on the Move

By | July 28, 2014

Health officials report the first case of Ebola virus disease outside of Guinea, Liberia, and Sierra Leone. A 40-year-old man has died in Nigeria.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham